TRIFOILIUM APS has a total of 16 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are YUYU PHARMA INC, LINXIS B V and AZTHERAPIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | China | 1 | |
#6 | Singapore | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Heslet Lars | 14 |
#2 | Fiala Kaare | 6 |
#3 | Kaare Fiala | 1 |
#4 | Heslet Lasse | 1 |
#5 | Lars Heslet | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014096032A1 | Gm-csf for treatment of chronic sinusitis | |
EP2877199A1 | Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma | |
EP2750696A1 | Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunction | |
EP2613773A2 | Airway administration of angiogenesis inhibitors | |
AU2011260713A1 | Trefoil factors (TFF) for the treatment of chronic pulmonary diseases |